全文获取类型
收费全文 | 14675篇 |
免费 | 1020篇 |
国内免费 | 152篇 |
专业分类
耳鼻咽喉 | 200篇 |
儿科学 | 336篇 |
妇产科学 | 164篇 |
基础医学 | 1814篇 |
口腔科学 | 229篇 |
临床医学 | 1166篇 |
内科学 | 3834篇 |
皮肤病学 | 301篇 |
神经病学 | 1013篇 |
特种医学 | 605篇 |
外科学 | 2118篇 |
综合类 | 197篇 |
一般理论 | 21篇 |
预防医学 | 1040篇 |
眼科学 | 349篇 |
药学 | 896篇 |
中国医学 | 55篇 |
肿瘤学 | 1509篇 |
出版年
2023年 | 92篇 |
2022年 | 59篇 |
2021年 | 295篇 |
2020年 | 237篇 |
2019年 | 330篇 |
2018年 | 372篇 |
2017年 | 352篇 |
2016年 | 394篇 |
2015年 | 439篇 |
2014年 | 550篇 |
2013年 | 684篇 |
2012年 | 1119篇 |
2011年 | 1069篇 |
2010年 | 665篇 |
2009年 | 526篇 |
2008年 | 1000篇 |
2007年 | 1109篇 |
2006年 | 986篇 |
2005年 | 1041篇 |
2004年 | 895篇 |
2003年 | 959篇 |
2002年 | 901篇 |
2001年 | 138篇 |
2000年 | 111篇 |
1999年 | 138篇 |
1998年 | 143篇 |
1997年 | 155篇 |
1996年 | 124篇 |
1995年 | 129篇 |
1994年 | 90篇 |
1993年 | 78篇 |
1992年 | 60篇 |
1991年 | 50篇 |
1990年 | 46篇 |
1989年 | 39篇 |
1988年 | 35篇 |
1987年 | 29篇 |
1986年 | 22篇 |
1985年 | 26篇 |
1984年 | 25篇 |
1983年 | 30篇 |
1982年 | 28篇 |
1981年 | 24篇 |
1980年 | 29篇 |
1978年 | 23篇 |
1977年 | 27篇 |
1976年 | 16篇 |
1973年 | 15篇 |
1970年 | 13篇 |
1966年 | 13篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
Yosuke Homma Takashi Shiga Hiraku Funakoshi Dai Miyazaki Atsushi Sakurai Yoshio Tahara Ken Nagao Naohiro Yonemoto Arino Yaguchi Naoto Morimura 《The American journal of emergency medicine》2019,37(2):241-248
Objective
This study assessed the association between the timing of first epinephrine administration (EA) and the neurological outcomes following out-of-hospital cardiac arrests (OHCAs) with both initial shockable and non-shockable rhythms.Methods
This was a post-hoc analysis of a multicenter prospective cohort study (SOS-KANTO 2012), which registered OHCA patients in the Kanto region of Japan from January 2012 to March 2013. We included consecutive adult OHCA patients who received epinephrine. The primary result included 1-month favorable neurological outcomes defined as cerebral performance category (CPC) 1 or 2. Secondary results included 1-month survival and return of spontaneous circulation (ROSC) after arrival at the hospital. Multivariable logistic regression analysis determined the association between delay per minute of the time from call to first EA in both pre- or in-hospital settings and outcomes.Results
Of the 16,452 patients, 9344 were eligible for our analyses. In univariable analysis, the delay in EA was associated with decreased favorable neurological outcomes only when the initial rhythm was a non-shockable rhythm. In multivariable analyses, delay in EA was associated with decreased ROSC (adjusted odds ratio [OR] for one minute delay, 0.97; 95% confidence interval [CI], 0.96–0.98) and 1-month survival (adjusted OR, 0.95; 95% CI, 0.92–0.97) when the initial rhythm was a non-shockable rhythm, whereas during a shockable rhythm, delay in EA was not associated with decreased ROSC and 1-month survival.Conclusions
While assessing the effectiveness of epinephrine for OHCA, we should consider the time-limited effects of epinephrine. Additionally, consideration of early EA based on the pathophysiology is needed. 相似文献3.
4.
5.
Takashi Inozume Ken‐ichi Hanada Kazuyo Takeda Tatsuo Maeda Kazutoshi Harada Tatsuyoshi Kawamura 《The Journal of dermatology》2019,46(1):52-56
Cytotoxic T‐lymphocyte‐associated protein 4 (CTLA‐4) is one of the important molecules that regulate the anti‐melanoma T‐cell response. Currently, there are some reports showing that CTLA‐4 is expressed not only by T cells but also by various kinds of tumor cells, including melanoma cells. However, there is no report that shows the role of CTLA‐4 expressed by melanoma cells in melanoma‐specific cytotoxic T‐lymphocyte (CTL) response. In this report, we confirmed substantial CTLA‐4 expression and the localization of CTLA‐4 in melanoma cell lines and tissues. Also, we examined its impact on melanoma‐specific CTL in vitro, and found that CTLA‐4 expressed by melanoma cells does not affect melanoma‐specific CTL in the effector phase. Our findings suggest the importance of elucidating the role of CTLA‐4 expressed by melanoma cells, particularly in anti‐CTLA‐4 antibody therapy. 相似文献
6.
High prevalence of toothache among Great East Japan Earthquake survivors living in temporary housing
7.
8.
目的建立UPLC-PDA法同时测定复方五凤草液(五凤草、白芨、猫爪草)中没食子酸、原儿茶酸、对羟基苯甲酸、咖啡酸、金丝桃苷、槲皮素、柚皮素的含有量。方法该药物80%甲醇提取液的分析采用Waters BEH C18色谱柱(2.1 mm×100 mm, 1.7μm);流动相乙腈-0.1%甲酸,梯度洗脱;体积流量0.3 mL/min;柱温40℃;检测波长266 nm。结果 7种成分在各自范围内线性关系良好(r≥0.999 5),平均加样回收率96.96%~102.26%,RSD 0.65%~2.10%。结论该方法稳定准确,重复性好,可用于复方五凤草液的质量控制。 相似文献
9.
Takeshi Nagashima Ken Yamaguchi Kenichi Urakami Yuji Shimoda Sumiko Ohnami Keiichi Ohshima Tomoe Tanabe Akane Naruoka Fukumi Kamada Masakuni Serizawa Keiichi Hatakeyama Kenya Matsumura Shumpei Ohnami Koji Maruyama Tohru Mochizuki Masatoshi Kusuhara Akio Shiomi Yasuhisa Ohde Masanori Terashima Katsuhiko Uesaka Tetsuro Onitsuka Seiichiro Nishimura Yasuyuki Hirashima Nakamasa Hayashi Yoshio Kiyohara Yasuhiro Tsubosa Hirohisa Katagiri Masashi Niwakawa Kaoru Takahashi Hiroya Kashiwagi Masahiro Nakagawa Yuji Ishida Takashi Sugino Mitsuru Takahashi Yasuto Akiyama 《Cancer science》2020,111(2):687-699
This study aimed to establish the Japanese Cancer Genome Atlas (JCGA) using data from fresh frozen tumor tissues obtained from 5143 Japanese cancer patients, including those with colorectal cancer (31.6%), lung cancer (16.5%), gastric cancer (10.8%) and other cancers (41.1%). The results are part of a single‐center study called “High‐tech Omics‐based Patient Evaluation” or “Project HOPE” conducted at the Shizuoka Cancer Center, Japan. All DNA samples and most RNA samples were analyzed using whole‐exome sequencing, cancer gene panel sequencing, fusion gene panel sequencing and microarray gene expression profiling, and the results were annotated using an analysis pipeline termed “Shizuoka Multi‐omics Analysis Protocol” developed in‐house. Somatic driver alterations were identified in 72.2% of samples in 362 genes (average, 2.3 driver events per sample). Actionable information on drugs that is applicable in the current clinical setting was associated with 11.3% of samples. When including those drugs that are used for investigative purposes, actionable information was assigned to 55.0% of samples. Germline analysis revealed pathogenic mutations in hereditary cancer genes in 9.2% of samples, among which 12.2% were confirmed as pathogenic mutations by confirmatory test. Pathogenic mutations associated with non–cancerous hereditary diseases were detected in 0.4% of samples. Tumor mutation burden (TMB) analysis revealed 5.4% of samples as having the hypermutator phenotype (TMB ≥ 20). Clonal hematopoiesis was observed in 8.4% of samples. Thus, the JCGA dataset and the analytical procedures constitute a fundamental resource for genomic medicine for Japanese cancer patients. 相似文献